Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
JPM 2022
Marketing
Argenx has big immunology goals, starting with Vyvgart rollout
With the launch of its first FDA-approved drug Vyvgart now underway, Argenx is charting a course to become an immunology “powerhouse” by 2025.
Fraiser Kansteiner
Jan 25, 2022 9:50am
Bristol's deucravacitinib not just another JAK drug, exec says
Jan 21, 2022 11:05am
AZ oncology R&D chief marks Imfinzi as 'core backbone'
Jan 20, 2022 2:40pm
Novo Nordisk plans more patient outreach as Wegovy launch rolls
Jan 19, 2022 1:28pm
Collaboration in biopharma is 'alive and well,' panel says
Jan 19, 2022 11:15am
BioMarin is underway with its 'biggest launch,' CEO says
Jan 14, 2022 11:23am
